These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34411006)

  • 1. Use of Suvorexant and Antipsychotics in the Treatment of Delirium After Infectious Diseases: A Retrospective Study.
    Okino K; Yamada H; Tomioka H; Nozaki S; Iwanami A; Inamoto A
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):589-593. PubMed ID: 34411006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients.
    Kawada K; Ohta T; Tanaka K; Miyamura M; Tanaka S
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):142-148. PubMed ID: 30322756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors.
    Hatta K; Kishi Y; Wada K; Takeuchi T; Hashimoto N; Suda K; Taira T; Tsuchida K; Ohmori T; Akizuki N; Nishio Y; Nakanishi Y; Usui C; Kurata A; Horikawa N; Eguchi H; Ito S; Muto H; Nakamura H; Uchimura N
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31851436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of Suvorexant for Complicated Delirium in Cancer Patients Who Experience Sleep Disturbance during Hospitalization].
    Kessoku T; Kusakabe A; Matsuura T; Honda Y; Yoshimi A; Goto A; Yoshida H; Sukegawa A; Hata C; Saito Y; Miyashita Y; Yashiro R; Komori T; Arai S; Nakajima A; Ichikawa Y
    Gan To Kagaku Ryoho; 2018 Mar; 45(Suppl 1):92-94. PubMed ID: 29650886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Persistent Delirium Resolved Promptly With Suvorexant.
    Inoue T; Morita M; Wada A; Kasai K; Kondo S
    Prim Care Companion CNS Disord; 2017 Apr; 19(2):. PubMed ID: 28453237
    [No Abstract]   [Full Text] [Related]  

  • 6. Significant decrease in delirium referrals after changing hypnotic from benzodiazepine to suvorexant.
    Tachibana M; Inada T; Ichida M; Kojima S; Arai T; Naito K; Ozaki N
    Psychogeriatrics; 2021 May; 21(3):324-332. PubMed ID: 33644945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive Effects of Suvorexant on Delirium: A Randomized Placebo-Controlled Trial.
    Hatta K; Kishi Y; Wada K; Takeuchi T; Ito S; Kurata A; Murakami K; Sugita M; Usui C; Nakamura H;
    J Clin Psychiatry; 2017; 78(8):e970-e979. PubMed ID: 28767209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suvorexant for the prevention of delirium: A meta-analysis.
    Xu S; Cui Y; Shen J; Wang P
    Medicine (Baltimore); 2020 Jul; 99(30):e21043. PubMed ID: 32791676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease: A Retrospective Cohort Study.
    Henmi R; Nakamura T; Mashimoto M; Takase F; Ozone M
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):369-377. PubMed ID: 38820374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Preventive Effects of Suvorexant in Intensive Care Delirium: A Retrospective Cohort Study.
    Izuhara M; Izuhara HK; Tsuchie K; Araki T; Ito T; Sato K; Miura S; Otsuki K; Nagahama M; Hayashida M; Hashioka S; Wake R; Kimura T; Tsumoto S; Saito Y; Inagaki M
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33027560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of suvorexant in the prevention of delirium during acute hospitalization: A systematic review.
    Adams AD; Pepin MJ; Brown JN
    J Crit Care; 2020 Oct; 59():1-5. PubMed ID: 32480359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for elderly patients with delirium in a general ward setting: A retrospective study.
    Ohsako N; Hashimoto T; Shiko Y; Kawasaki Y; Nakagawa M; Okuma T; Kurata T; Suzuki H; Ishige M; Kikuchi S
    Asian J Psychiatr; 2022 Apr; 70():103024. PubMed ID: 35219983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suvorexant is associated with a low incidence of delirium in critically ill patients: a retrospective cohort study.
    Masuyama T; Sanui M; Yoshida N; Iizuka Y; Ogi K; Yagihashi S; Nagatomo K; Sasabuchi Y; Lefor AK
    Psychogeriatrics; 2018 May; 18(3):209-215. PubMed ID: 29423967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.
    Michelson D; Snyder E; Paradis E; Chengan-Liu M; Snavely DB; Hutzelmann J; Walsh JK; Krystal AD; Benca RM; Cohn M; Lines C; Roth T; Herring WJ
    Lancet Neurol; 2014 May; 13(5):461-71. PubMed ID: 24680372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit.
    Azimaraghi O; Hammer M; Santer P; Platzbecker K; Althoff FC; Patrocinio M; Grabitz SD; Wongtangman K; Rumyantsev S; Xu X; Schaefer MS; Fuller PM; Subramaniam B; Eikermann M
    BMJ Open; 2020 Jul; 10(7):e038474. PubMed ID: 32690536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suvorexant with or without ramelteon to prevent delirium: a systematic review and meta-analysis.
    Tian Y; Qin Z; Han Y
    Psychogeriatrics; 2022 Mar; 22(2):259-268. PubMed ID: 34881812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive Effect of Suvorexant for Postoperative Delirium after Coronary Artery Bypass Grafting.
    Tamura K; Maruyama T; Sakurai S
    Ann Thorac Cardiovasc Surg; 2019 Feb; 25(1):26-31. PubMed ID: 30089761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suvorexant for the Treatment of Insomnia in Adolescents.
    Kawabe K; Horiuchi F; Ochi M; Nishimoto K; Ueno SI; Oka Y
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):792-795. PubMed ID: 28520464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2014 Dec; 68(12):1429-41. PubMed ID: 25231363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating delirium in a general hospital: a descriptive study of prescribing patterns and outcomes.
    Briskman I; Dubinski R; Barak Y
    Int Psychogeriatr; 2010 Mar; 22(2):328-31. PubMed ID: 19785917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.